NKTR
NEKTAR THERAPEUTICS
+1.47 (+2.17%)68.85USD304K成交股數2.4B市值–本益比(近四季)43.1股價營收比-9.3%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 10.1M-9% | 10.9M+4% | 21.8M-10% | 11.8M-50% | 11.2M-48% | 10.5M-56% | 24.1M-0% | 23.5M+15% | 21.6M | 23.9M | 24.1M | 20.5M |
| 營業成本 | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 4.4M | 9.7M | 8.5M | 7.3M | 12.4M | 7.0M |
| 毛利 | – | – | 21.8M+11% | 11.8M-14% | 11.2M-15% | 10.5M-37% | 19.7M+68% | 13.7M+2% | 13.1M | 16.6M | 11.7M | 13.5M |
| 毛利率 | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 81.6% | 58.5% | 60.6% | 69.5% | 48.5% | 65.9% |
| 研發費用 | 39.1M | 35.7M | 29.7M | 27.3M | 29.9M | 30.5M | 35.0M | 29.7M | 27.4M | 29.9M | 24.1M | 29.7M |
| 銷售管理費用 | 12.8M | 13.4M | 11.2M | 16.1M | 17.1M | 24.3M | 19.0M | 20.5M | 20.1M | 17.3M | 21.1M | 17.9M |
| 營業利益 | −42.3M+17% | −39.1M-12% | −27.7M-19% | −31.7M-36% | −36.2M+2% | −44.5M+33% | −34.3M-23% | −49.8M-2% | −35.4M | −33.5M | −44.9M | −50.6M |
| 營業利益率 | -417.9% | -359.6% | -126.9% | -268.6% | -324.2% | -425.8% | -142.4% | -211.9% | -163.7% | -140.3% | -185.8% | -246.8% |
| 稅後淨利 | −40.6M-2% | −44.9M-12% | −36.0M-3% | −35.5M-32% | −41.6M+13% | −50.9M+21% | −37.1M-19% | −52.4M+2% | −36.8M | −42.0M | −45.8M | −51.1M |
| 淨利率 | -401.0% | -413.4% | -165.1% | -301.3% | -372.2% | -486.4% | -153.6% | -222.9% | -170.1% | -175.9% | -189.8% | -249.4% |
| 稀釋 EPS | -1.23-58% | -1.82-50% | -1.29-52% | -1.87-50% | -2.95+1453% | -3.62+1624% | -2.66+1008% | -3.76+1293% | -0.19 | -0.21 | -0.24 | -0.27 |
| 稀釋股數 | 33.1M | 24.7M | 16.9M | 18.9M | 14.1M | 14.1M | 13.9M | 13.9M | 195M | 190M | 190M | 190M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 39.3M | 150M | 15.1M | 41.0M | 43.0M | 38.9M | 30.1M | 27.9M | 48.6M | 35.3M | 64.9M | 50.7M |
| 應收帳款 | – | – | – | – | – | – | 0.00 | 1.2M | 3.6M | 1.2M | 2.2M | 1.3M |
| 存貨 | – | – | 0.00 | – | – | – | 0.00 | 14.5M | 16.2M | 16.1M | 15.1M | 20.7M |
| 總資產 | 1.1B | 763M | 280M | 301M | 208M | 256M | 308M | 343M | 396M | 398M | 442M | 494M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 192M | 187M | 191M | 216M | 232M | 243M | 259M | 264M | 269M | 267M | 283M | 297M |
| 股東權益 | 903M | 576M | 89.8M | 85.1M | −24.2M | 13.7M | 48.9M | 79.7M | 127M | 131M | 159M | 197M |
| 負債比 | 17.5% | 24.5% | 68.0% | 71.8% | 111.7% | 94.6% | 84.1% | 76.8% | 68.0% | 67.1% | 64.0% | 60.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −44.3M-10% | – | – | – | −49.1M | – | – | −47.9M | – | – | – |
| 資本支出 | – | 18K | – | – | – | 2K | – | – | 157K | – | – | – |
| 自由現金流 | – | −44.3M-10% | – | – | – | −49.1M | – | – | −48.0M | – | – | – |
| 折舊攤銷 | – | 151K | – | – | – | 426K | – | – | 1.6M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | 0.00 | – | – | 3.0M | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -408.0% | – | – | – | -469.0% | – | – | -222.0% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 55.2M
| Non Cash Royalties | 54.9M | 99.5% | -14.6% |
|---|---|---|---|
| License Collaboration And Other Revenue | 300K | 0.5% | -49.7% |
| Non Cash Royalty Revenue Related To Sale Of Future Royalties 小計 | 54.9M | 99.5% | -14.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 55.2M | -43.9% | −164M | -296.9% | -9.73 | −209M |
| FY2024 | 98.4M | +9.2% | −119M | -120.9% | -8.68 | −177M |
| FY2023 | 90.1M | -2.1% | −276M | -306.3% | -1.45 | −193M |
| FY2022 | 92.1M | -9.7% | −368M | -399.8% | -1.97 | −310M |
| FY2021 | 102M | -33.4% | −524M | -514.2% | -2.86 | −428M |
| FY2020 | 153M | +33.4% | −444M | -290.6% | -2.49 | −321M |
| FY2019 | 115M | -90.4% | −441M | -384.5% | -2.52 | −355M |
| FY2018 | 1.2B | – | 681M | 57.1% | 3.78 | 704M |